Seven Bridges Genomics
Latest round
- Seed
Last raised
- Sep 2014
Total raised
- $3M
Investors
- 1
About Seven Bridges Genomics
Founded in 2009 in Cambridge, US, Seven Bridges Genomics specializes in bioinformatics.714 mn.Seven Bridges Genomics, now operating under the name Velsera, delivers a suite of end-to-end bioinformatic solutions designed to accelerate healthcare research and development. Their primary offerings include cloud-computing infrastructure, analytic workflows, and access to extensive genomic datasets. The platform enables scientists and researchers in biopharma, healthcare, and academia to organize, explore, and analyze genomic and clinical data efficiently. This functionality allows users to streamline clinical trials, enhance drug discovery processes, and optimize biomarker identification.Seven Bridges Genomics operates on a revenue structure that includes subscription-based models and partnerships with organizations in the biopharma and healthcare sectors. Clients are typically engaged through transactional agreements that provide them access to the company’s flagship products such as the ARIA, GRAF, and RHEO platforms. These agreements may involve tiered pricing plans depending on the extent of data access and computational resources required. With a focus on B2B transactions, the company's revenue is generated by providing tailored bioinformatics solutions that facilitate advanced research capabilities for its clientele. The company is developing new features and tools that are anticipated to launch in the next 12 months, aimed at improving data analytics capabilities for its users. Additionally, Seven Bridges is targeting further penetration into markets in Europe and Asia by the end of the upcoming fiscal year, aiming to provide tailored solutions to meet the unique demands of researchers in these regions. Recent transactions indicate a strategic shift towards increasing their global footprint and enhancing product accessibility.
Who invested in Seven Bridges Genomics
1 investor across 1 round
See all investors in Seven Bridges Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 1, 2014
Amount
$3M
Investors
Questions about Seven Bridges Genomics
Who invested in Seven Bridges Genomics?
Seven Bridges Genomics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Seven Bridges Genomics raised?
Seven Bridges Genomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Seven Bridges Genomics last raise money?
Seven Bridges Genomics's most recent round on record is a Seed, in Sep 2014.
What does Seven Bridges Genomics do?
Founded in 2009 in Cambridge, US, Seven Bridges Genomics specializes in bioinformatics.
Where is Seven Bridges Genomics headquartered?
Seven Bridges Genomics is headquartered in Cambridge, US.
Which VCs invest in companies like Seven Bridges Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Seven Bridges Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Seven Bridges Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.